nach oben

Journal of Neuro-Oncology

Erschienen in:

01.01.2011 | Topic Review

The pseudocapsule surrounding a pituitary adenoma and its clinical significance

verfasst von: Xin Qu, Guangming Xu, Yuanming Qu, Tao Song

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

The transsphenoidal approach is currently considered the preferred first-line treatment for pituitary adenoma. With the discovery and application of the pseudocapsule surrounding a pituitary adenoma, transsphenoidal surgery of pituitary adenoma further falls into two categories: “extracapsular” and traditional “intracapsular” resection methods, on the basis of where dissection is performed with respect to the pseudocapsule. Thus, the pseudocapsule can be used as a plane to guide the operation, helps in total resection of pituitary adenoma, and can guide subsequent treatment after surgery.

Annegers JF, Coulam CB, Abboud CF, Laws ER Jr, Kurland LT (1978) Pituitary adenoma in Olmsted County, Minnesota, 1935–1977. A report of an increasing incidence of diagnosis in women of childbearing age. Mayo Clin Proc 53:641–643PubMed

Jane JA, Laws ER (2001) The surgical management of pituitary adenomas in a series of 3, 093 patients. J Am Coll Surg 193:650–659. doi:10.1016/S1072-7515(01)01101-2 CrossRef

Asa SL, Ezzat S (1998) The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798–827. doi:10.1210/er.19.6.798 CrossRefPubMed

Kawamata T, Iseki H, Shibasaki T, Hori T (2002) Endoscopic augmented reality navigation system for endonasal transsphenoidal surgery to treat pituitary tumors: technical note. Neurosurgery 50:1393–1397. doi:10.1097/00006123-200206000-00038 CrossRefPubMed

Lee EJ, Ahn JY, Noh T, Kim SH, Kim TS (2009) Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma? Neurosurgery 64:62–69. doi:10.1227/01.NEU.0000330406.73157.49 CrossRefPubMed

Koren I, Hadar T, Rappaport ZH, Yaniv E (1999) Endoscopic transnasal transsphenoidal microsurgery versus the sublabial approach for the treatment of pituitary tumors: endonasal complications. Laryngoscope 109:1838–1840. doi:10.1097/00005537-199911000-00022 CrossRefPubMed

Couldwell WT (2004) Transsphenoidal and transcranial surgery for pituitary adenomas. J Neurooncol 69:237–256. doi:10.1023/B:NEON.0000041886.61149.ab CrossRefPubMed

Liu JK, Das K, Weiss MH, Laws ER Jr, Couldwell WT (2001) The history and evolution of transsphenoidal surgery. J Neurosurg 95:1083–1096. doi:10.3171/jns.2001.95.6.1083 CrossRefPubMed

Mortini P, Losa M, Barzaghi R, Boari N, Giovanelli M (2005) Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56:1222–1233. doi:10.1227/01.NEU.0000159647.64275.9D CrossRefPubMed

10.

Oldfield EH, Vortmeyer AO (2006) Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors. J Neurosurg 104:7–19. doi:10.3171/jns.2006.104.1.7 CrossRefPubMed

11.

Costello RT (1936) Subclinical adenoma of the pituitary gland. Am J Pathol 12:205–216PubMed

12.

Jagannathan J, Smith R, Devroom HL, Vortmeyer AO, Stratakis CA, Nieman LK, Oldfield EH (2009) Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J Neurosurg 111:531–539. doi:10.3171/2008.8.JNS08339 CrossRefPubMed

13.

Kawamata T, Kubo O, Hori T (2005) Surgical removal of growth hormone-secreting pituitary adenomas with intensive microsurgical pseudocapsule resection results in complete remission of acromegaly. Neurosurg Rev 28:201–208. doi:10.1007/s10143-005-0384-7 CrossRefPubMed

14.

Peker S, Kurtkaya-Yapicier O, Kilic T, Pamir MN (2005) Microsurgical anatomy of the lateral walls of the pituitary fossa. Acta Neurochir (Wien) 147:641–648. doi:10.1007/s00701-005-0513-7 CrossRef

15.

Qi ST, Lu YT, Pan J, Huang CP, Shi XS (2009) Membranous layers of the pituitary gland: histological anatomic study and related clinical issues. Neurosurgery 64:1–9. doi:10.1227/01.NEU.0000327688.76833.F7 CrossRef

16.

Yasuda A, Campero A, Martins C, Rhoton AL Jr, Ribas GC (2004) The medial wall of the cavernous sinus: microsurgical anatomy. Neurosurgery 55:179–189. doi:10.1227/01.NEU.0000126953.59406.77 CrossRefPubMed

17.

Ciric I (1977) On the origin and nature of the pituitary gland capsule. J Neurosurg 46:596–600. doi:10.3171/jns.1977.46.5.0596 CrossRefPubMed

18.

Chi JG, Lee MH (1980) Anatomical observations of the development of the pituitary capsule. J Neurosurg 52:667–670. doi:10.3171/jns.1980.52.5.0667 CrossRefPubMed

19.

Destrieux C, Kakou MK, Velut S, Lefrancq T, Jan M (1998) Microanatomy of the hypophyseal fossa boundaries. J Neurosurg 88:743–752. doi:10.3171/jns.1998.88.4.0743 CrossRefPubMed

20.

Hardy J (1975) Transsphenoidal microsurgical removal of pituitary adenoma. Prog Neurol Surg 6:200–216

21.

Bergland R (1975) Pathological considerations in pituitary tumors. Prog Neurol Surg 6:62–94

22.

Wrightson P (1978) Conservative removal of small pituitary tumours: is it justified by the pathological findings? J Neurol Neurosurg Psychiatry 41:283–289. doi:10.1136/jnnp.41.3.283 CrossRefPubMed

23.

Hashimoto N, Handa H, Yamagami T (1986) Transsphenoidal extracapsular approach to pituitary tumors. J Neurosurg 64:16–20. doi:10.3171/jns.1986.64.1.0016 CrossRefPubMed

24.

Kouri JG, Chen MY, Watson JC, Oldfield EH (2000) Resection of suprasellar tumors by using a modified transsphenoidal approach. Report of four cases. J Neurosurg 92:1028–1035. doi:10.3171/jns.2000.92.6.1028 CrossRefPubMed

25.

Kaptain GJ, Vincent DA, Sheehan JP, Laws ER Jr (2001) Transsphenoidal approaches for the extracapsular resection of midline suprasellar and anterior cranial base lesions. Neurosurgery 49:94–101. doi:10.1227/01.neu.0000333791.29091.83 CrossRefPubMed

26.

Chacko AG, Chacko G, Seshadri MS, Chandy MJ (2003) The ‘capsule’ of pituitary macroadenomas represents normal pituitary gland: a histopathological study. Br J Neurosurg 17:213–218. doi:10.1080/0268869031000153099 CrossRefPubMed

27.

Farnoud MR, Kujas M, Derome P, Racadot J, Peillon F, Li JY (1994) Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas. An immunohistochemical study. Virchows Arch 424:75–82. doi:10.1007/BF00197396 CrossRefPubMed

28.

Laws ER Jr (2006) Pituitary pseudocapsule. J Neurosurg 104:1–2. discussison 2–3. doi:10.3171/jns.2006.104.1.1

29.

Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S (1990) Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427–1433. doi:10.1210/jcem-71-6-1427 CrossRefPubMed

30.

Schulte HM, Oldfield EH, Allolio B, Katz DA, Berkman RA, Ali IU (1991) Clonal composition of pituitary adenomas in patients with Cushing’s disease: determination by X-Chromosome inactivation analysis. J Clin Endocrinol Metab 73:1302–1308. doi:10.1210/jcem-73-6-1302 CrossRefPubMed

31.

Gicquel C, Le Bouc Y, Luton JP, Girard F, Bertagna X (1992) Monoclonality of corticotroph macroadenomas in Cushing’s disease. J Clin Endocrinol Metab 75:472–475. doi:10.1210/jc.75.2.472 CrossRefPubMed

32.

Weil RJ, Vortmeyer AO, Nieman LK, DeVroom HL, Wanebo J, Oldfield EH (2006) Surgical remission of pituitary adenomas confined to the neurohypophysis in Cushing’s disease. J Clin Endocrinol Metab 91:2656–2664. doi:10.1210/jc.2006-0277 CrossRefPubMed

33.

Teramoto A, Sano K, Osamura RY, Watanabe K (1979) Immunohistochemical observations of the pituitary adenomas with the use of enzyme-labelled antibody method-on the residual pituitary gland and “capsule” of the adenoma [in Japanese]. Neurol Med Chir (Tokyo) 19:895–902. doi:10.2176/nmc.19.895 CrossRef

34.

Teramoto A, Takakura K, Fukushima T (1982) The clinico-pathological study on the boundary of pituitary adenomas. No To Shinkei 34:887–894PubMed

35.

Bevan JS, Webster J, Burke CW, Scanlon MF (1992) Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13:220–240PubMed

36.

Kontogeorgos G, Horvath E, Kovacs K, Coire C, Lloyd RV, Scheithauer BW, Smyth HS (2006) Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists. Acta Neuropathol 111:46–52. doi:10.1007/s00401-005-1111-8 CrossRefPubMed

37.

Kanter AS, Dumont AS, Asthagiri AR, Oskouian RJ, Jane JA Jr, Laws ER Jr (2005) The transsphenoidal approach. A historical perspective. Neurosurg Focus 18:1–4. doi:10.3171/foc.2005.18.4.7 CrossRef

38.

Dickerman RD, Oldfield EH (2002) Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97:1343–1349. doi:10.3171/jns.2002.97.6.1343 CrossRefPubMed

39.

Ciric I, Rosenblatt S, Zhao JC (2002) Transsphenoidal microsurgery. Neurosurgery 51:161–169. doi:10.1097/00006123-200207000-00023 CrossRefPubMed

40.

Rabadan AT, Hernandez D, Ruggeri CS (2009) Pituitary tumors: our experience in the prevention of postoperative cerebrospinal fluid leaks after transsphenoidal surgery. J Neurooncol 93:127–131. doi:10.1007/s11060-009-9858-8 CrossRefPubMed

41.

Black PM, Zervas NT, Candia GL (1987) Incidence and management of complications of transsphenoidal operation for pituitary adenomas. Neurosurgery 20:920–924. doi:10.1097/00006123-198706000-00017 CrossRefPubMed

42.

Thapar K, Laws ER Jr (2003) Pituitary tumors: functioning and non-functioning. In: Winn H (ed) Youmans neurological surgery, 5th edn. Saunders, Philadelphia, pp 1169–1206

43.

Thapar K, Kovacs K, Horvath E, Asa SL (1996) Classification and pathology of pituitary tumors. In: Wilkins RH, Rengachary SS (eds) Neurosurgery, 2nd edn. McGraw-Hill, New York, pp 1273–1289

44.

Kuwayama A (2003) Treatment and long-term results of Cushing disease. Folia Endocrinol Jpn 79:17–19

45.

Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692–696. doi:10.1038/340692a0 CrossRefPubMed

46.

Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR et al (1990) Two G protein oncogenes in human endocrine tumors. Science 249:655–659. doi:10.1126/science.2116665 CrossRefPubMed

47.

Qian ZR, Asa SL, Siomi H, Siomi MC, Yoshimoto K, Yamada S, Wang EL, Rahman MM, Inoue H, Itakura M, Kudo E, Sano T (2009) Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod Pathol 22:431–441. doi:10.1038/modpathol.2008.202 CrossRefPubMed

48.

Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617CrossRefPubMed

49.

Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF (2008) The endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience. Neurosurgery 63:244–256. doi:10.1227/01.NEU.0000327025.03975.BA CrossRefPubMed

Titel: The pseudocapsule surrounding a pituitary adenoma and its clinical significance
verfasst von: Xin Qu
Guangming Xu
Yuanming Qu
Tao Song
Publikationsdatum: 01.01.2011
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 2/2011
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-010-0247-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Pineal parenchymal tumor of intermediate differentiation with papillary features: a continuum of primary pineal tumors?

Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors

Low incidence of brain tumors among Ethiopian immigrants in Israel

Radiographic patterns of relapse in glioblastoma

Erratum to: Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review